Last reviewed · How we verify
Opioid-Based Patient Controlled Analgesia — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Opioid-Based Patient Controlled Analgesia (Opioid-Based Patient Controlled Analgesia) — Taipei Veterans General Hospital, Taiwan.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Opioid-Based Patient Controlled Analgesia TARGET | Opioid-Based Patient Controlled Analgesia | Taipei Veterans General Hospital, Taiwan | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Opioid-Based Patient Controlled Analgesia CI watch — RSS
- Opioid-Based Patient Controlled Analgesia CI watch — Atom
- Opioid-Based Patient Controlled Analgesia CI watch — JSON
- Opioid-Based Patient Controlled Analgesia alone — RSS
Cite this brief
Drug Landscape (2026). Opioid-Based Patient Controlled Analgesia — Competitive Intelligence Brief. https://druglandscape.com/ci/opioid-based-patient-controlled-analgesia. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab